Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RC Jr. Fu S, et al. Cancer. 2011 Apr 15;117(8):1661-9. doi: 10.1002/cncr.25701. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472713 Free PMC article. Clinical Trial.
Targeting Aurora kinases in ovarian cancer.
Fu S, Hu W, Kavanagh JJ, Bast RC Jr. Fu S, et al. Expert Opin Ther Targets. 2006 Feb;10(1):77-85. doi: 10.1517/14728222.10.1.77. Expert Opin Ther Targets. 2006. PMID: 16441230 Review.
Update on aurora kinase inhibitors in gynecologic malignancies.
Tao X, Chon HS, Fu S, Kavanagh JJ, Hu W. Tao X, et al. Among authors: fu s. Recent Pat Anticancer Drug Discov. 2008 Nov;3(3):162-77. doi: 10.2174/157489208786242322. Recent Pat Anticancer Drug Discov. 2008. PMID: 18991785 Free PMC article. Review.
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.
Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R. Tsimberidou AM, et al. Among authors: fu s. Cancer Chemother Pharmacol. 2010 Nov;66(6):1087-93. doi: 10.1007/s00280-010-1266-4. Epub 2010 Mar 4. Cancer Chemother Pharmacol. 2010. PMID: 20204368 Free PMC article. Clinical Trial.
8,388 results